您的位置: 专家智库 > >

国家自然科学基金(30571988)

作品数:6 被引量:35H指数:4
相关作者:魏文斌史雪辉杨承勋康媚霞崔蕾更多>>
相关机构:首都医科大学中国医学科学院北京协和医学院更多>>
发文基金:国家自然科学基金北京市自然科学基金首都医学发展科研基金更多>>
相关领域:医药卫生农业科学更多>>

文献类型

  • 6篇中文期刊文章

领域

  • 5篇医药卫生
  • 1篇农业科学

主题

  • 3篇黑色素
  • 3篇黑色素瘤
  • 2篇葡萄膜
  • 2篇肿瘤
  • 2篇肿瘤标志
  • 2篇肿瘤标志物
  • 2篇MIRNA
  • 2篇标志物
  • 1篇蛋白
  • 1篇蛋白质
  • 1篇蛋白质组
  • 1篇蛋白质组学
  • 1篇电泳
  • 1篇双向凝胶电泳
  • 1篇凝胶
  • 1篇凝胶电泳
  • 1篇葡萄膜恶性黑...
  • 1篇葡萄膜黑色素...
  • 1篇相关蛋白
  • 1篇脉络膜

机构

  • 3篇首都医科大学
  • 1篇中国医学科学...

作者

  • 3篇魏文斌
  • 2篇史雪辉
  • 1篇崔蕾
  • 1篇康媚霞
  • 1篇杨承勋

传媒

  • 2篇Chines...
  • 1篇眼科
  • 1篇眼科新进展
  • 1篇Scienc...
  • 1篇中国科学:生...

年份

  • 1篇2011
  • 2篇2010
  • 2篇2008
  • 1篇2007
6 条 记 录,以下是 1-6
排序方式:
Local excision of ciliary body tumors: a long-term prospective cohort study in China被引量:7
2008年
Background Ciliary body tumors are usually difficult to diagnose and treat in early stages. However, treatment of such tumors has trended toward ocular conservation instead of enucleation. Local excision of ciliary body tumors has become effective with the development of the modern vitrectomy, but long-term outcomes are still not clear. Therefore, we reported the outcome of locally excised ciliary body tumors after long-term follow-up. Methods Twenty-two patients (22 eyes), who had been diagnosed with ciliary body tumors in Beijing Tongren Hospital from January 1996 to June 2001, were enrolled in this prospective cohort study. Localized lamellar sclera-ciliary excisions were performed. In some cases, vitrectomies, scleral graft transplantations, and further excisions of the anterior choroid were performed. Diagnoses were confirmed by histopathologic examination. Patients were followed from five to eleven years after surgery. Their visual acuity, intraocular pressure and local recurrence were recorded with descriptive percentages. Results After surgery, all patients maintained normal eyeball appearances. Six patients maintained circular pupils. The final best corrected visual acuities (BCVA) varied from 0.02-1.00, including 18 patients (81.82%) who had BCVA equal to or better than that before surgery. Fifteen patients (68.18%) had BCVA better than 0.3. Only two patients had intraocular pressure (lOP) of less than 10 mmHg and the other patients maintained normal lOP. Nine cases (40.91%) were given confirmed diagnosis of malignant melanoma, four (18.18%) of melanocytoma, six (27.27%) of nonpigmented ciliary epithelial adenoma, two (9.09%) of neurofibroma, and one (4.55%) of neurinoma. Twenty patients (90.91%) had no recurrence during the follow-up period. In one case melanocytoma recurred seven years after surgery and enucleation was performed. One patient, whose operation removed a malignant melanoma with a diameter of 16 mm, died of hepatic metastasis five years after th
WEI Wen-bin YANG Wen-li HU Shi-min LI Bin
葡萄膜恶性黑色素瘤肿瘤标志物研究进展被引量:4
2007年
葡萄膜恶性黑色素瘤(uveal melanoma,UM)是成人最常见的眼内原发性恶性肿瘤,在其发生发展过程中可释放多种肿瘤标志物(tumor marker,TM)。寻求有价值的特异性TM对UM早期诊断、靶向治疗和判断预后具有重要意义。我们对UM蛋白标志物及其近年来研究进展作一综述。
史雪辉魏文斌
关键词:葡萄膜恶性黑色素瘤肿瘤标志物
Choroidal malignant melanoma in patients with oculodermal melanocytosis: report of three cases被引量:4
2010年
Oculodermal melanocytosis (ODM) is a congenital melanocytic pigmentary disorder involving eyetissue. It is a congenital ocular pigmentation with associated melanocytic deposition in the surrounding dermis. In 1939, Ota and Taninol first gave a definitive description of cutaneous hyperpigmentation along the trigeminal nerve distribution in addition to bulbar involvement, called oculodermal melanocytosis (nevus of Ota). Oculodermal melanocytosis is a well-recognized risk factor for the development of choroidal malignant melanoma, especially in white patients. Gonder et al2,3 reported ODM is about 35 times more common in the uveal melanoma population. We report three cases of choroidal malignant melanoma in oculodermal melanocytosis patients.
YANG Qiong WEI Wen-bin YANG Wen-li LI Bin WANG Guang-lu
The miRNA expression profile of the uveal melanoma被引量:17
2011年
The miRNA expression profile was initially established to investigate its corresponding function in human uveal melanoma. The miRNA expression profile in human uveal melanoma was analyzed by a micro chip technique.The hsa-miRNA expression between four uveal melanomas and four normal uveal tissues was compared.Based on the bioinformatic approach,chip data was analyzed to select out differentially expressed candidate hsa-miRNAs.Real-time quantitative PCR(RT-PCR) was used to confirm the candidate hsa-miRNAs expression in all samples.The results of miRNA microarray chips that matched with RT-PCR were considered as the miRNA expression which was significantly different between normal tissue and uveal melanomas.In four uveal melanomas,expressions of miRNA-20a,miRNA-106a,miRNA-17,miRNA-21,and miRNA-34a were significantly up-regulated,while miRNA-145 and miRNA-204 expression were significantly down-regulated.We used miRNA microarray analysis as a fast,efficient technology to study biological information.The differentially expressed miRNAs may be involved in uveal melanoma pathogenesis,and may help promote the diagnosis and treatment for uveal melanoma.
YANG ChengHsun
关键词:MIRNATUMORIGENESIS
比较蛋白质组学技术筛选葡萄膜黑色素瘤相关蛋白
2008年
目的应用比较蛋白质组学技术,分析鉴定葡萄膜黑色素瘤与正常人葡萄膜差异蛋白质,筛选出葡萄膜黑色素瘤相关蛋白。设计实验性研究。研究对象手术中切除的人葡萄膜黑色素瘤标本4例以及正常人捐献眼葡萄膜标本4例。方法研磨组织提取蛋白质后,应用双向凝胶电泳进行总蛋白分离,考马斯亮兰染色,Image Master 5.0软件分析蛋白胶图。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)鉴定部分差异蛋白质点,通过MASCOT软件在NCBI数据库中检索蛋白质信息。主要指标差异蛋白质。结果建立了葡萄膜黑色素瘤和正常人葡萄膜组织的双向凝胶电泳图谱,鉴定了葡萄膜黑色素瘤与正常人葡萄膜之间差异表达的蛋白质30种,其中24种蛋白只在葡萄膜黑色素瘤中出现。葡萄膜黑色素瘤中表达上调的蛋白5种,表达下调的蛋白1种。这些差异蛋白可能执行新陈代谢酶、信号转导调节、细胞骨架、免疫调节等生物学功能。结论通过比较蛋白质组学初步筛选出与葡萄膜黑色素瘤发生演进相关的蛋白质。需要进一步验证蛋白的定位及功能。
康媚霞魏文斌史雪辉崔蕾
关键词:葡萄膜黑色素瘤蛋白质组学双向凝胶电泳
脉络膜黑色素瘤miRNA表达谱的初步研究被引量:3
2010年
初步建立人脉络膜黑色素瘤的miRNA表达谱,并探讨相应的miRNA在该疾病中的功能,为阐明脉络膜黑色素瘤发病机制寻求有效的治疗途径提供理论和实验依据.利用miRNA微芯片技术检测脉络膜黑色素瘤的has-miRNA表达谱,将4例人脉络膜黑色素瘤组织总RNA分别与4例健康人脉络膜组织对比,筛选has-miRNA表达情况.根据生物信息学的有关方法处理芯片实验数据,筛选出共同差异表达的候选has-miRNA.采用实时定量PCR的方法,验证各候选has-miRNA的表达情况.将芯片和RT-PCR两种方法结论一致的候选hsa-miRNA确定为有意义的共同差异表达has-miRNA.运用miRNA芯片技术,发现人脉络膜黑色素瘤组织中miRNA-20a,miRNA-106a,miRNA-17,miRNA-21,miRNA-34a明显上调表达,miRNA-145和miRNA-204明显下调表达.在4例脉络膜黑色素瘤中,miRNA-20a,miRNA-106a,miRNA-17,miRNA-21,miRNA-34a明显表达上调,miRNA-145和miRNA-204明显表达下调.脉络膜黑色素瘤有差异表达的miRNA为研究肿瘤的发生机制研究提供了诊断和治疗的新思路.
杨承勋魏文斌
关键词:脉络膜黑色素瘤MIRNA肿瘤标志物
共1页<1>
聚类工具0